Global Recombinant Human Bone Morphogenetic Protein (rhBMP) Market Growth 2024-2030

Global Recombinant Human Bone Morphogenetic Protein (rhBMP) Market Growth 2024-2030

Bone morphogenetic proteins (BMPs) are a group of growth factors also known as cytokines and as metabologens. Recombinant human bone morphogenetic proteins (rhBMPs) are used in orthopedic applications such as spinal fusions, nonunions, and oral surgery. rhBMP-2 and rhBMP-7 are Food and Drug Administration (FDA)-approved for some uses. rhBMP-2 causes more overgrown bone than any other BMPs and is widely used off-label.

The global Recombinant Human Bone Morphogenetic Protein (rhBMP) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Recombinant Human Bone Morphogenetic Protein (rhBMP) Industry Forecast” looks at past sales and reviews total world Recombinant Human Bone Morphogenetic Protein (rhBMP) sales in 2023, providing a comprehensive analysis by region and market sector of projected Recombinant Human Bone Morphogenetic Protein (rhBMP) sales for 2024 through 2030. With Recombinant Human Bone Morphogenetic Protein (rhBMP) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Human Bone Morphogenetic Protein (rhBMP) industry.

This Insight Report provides a comprehensive analysis of the global Recombinant Human Bone Morphogenetic Protein (rhBMP) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Human Bone Morphogenetic Protein (rhBMP) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Human Bone Morphogenetic Protein (rhBMP) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Human Bone Morphogenetic Protein (rhBMP) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Human Bone Morphogenetic Protein (rhBMP).

United States market for Recombinant Human Bone Morphogenetic Protein (rhBMP) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Recombinant Human Bone Morphogenetic Protein (rhBMP) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Recombinant Human Bone Morphogenetic Protein (rhBMP) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Recombinant Human Bone Morphogenetic Protein (rhBMP) players cover Medtronic, DePuy Synthes, Jiuyuan Gene Engineering, Cellumed, Yantai Zhenghai Bio-Tech, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Human Bone Morphogenetic Protein (rhBMP) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

rhBMP-2

rhBMP-7

Segmentation by Application:

Spinal Fusion

Trauma Surgery

Oral Maxillofacial Surgery

Reconstructive

This report also splits the market by region:

Americas
United States
Canada
Mexico
Brazil

APAC
China
Japan
Korea
Southeast Asia
India
Australia

Europe
Germany
France
UK
Italy
Russia

Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Medtronic

DePuy Synthes

Jiuyuan Gene Engineering

Cellumed

Yantai Zhenghai Bio-Tech

Key Questions Addressed in this Report

What is the 10-year outlook for the global Recombinant Human Bone Morphogenetic Protein (rhBMP) market?

What factors are driving Recombinant Human Bone Morphogenetic Protein (rhBMP) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Recombinant Human Bone Morphogenetic Protein (rhBMP) market opportunities vary by end market size?

How does Recombinant Human Bone Morphogenetic Protein (rhBMP) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.